Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes
PHASE4CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Endothelial Graft Rejection
Interventions
DRUG
Sandimmune
DRUG
Artelose
Trial Locations (2)
16666
Ophthalmic Research Center, Tehran
166666
Ophthalmic Research Center, Tehran
All Listed Sponsors
lead
Shahid Beheshti University of Medical Sciences
OTHER
NCT01028443 - Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes | Biotech Hunter | Biotech Hunter